582
M. M. HERAVI ET AL.
2
3
4
5
6
7
. Berlin, K. D.; Herd, M. D. Novel 2-amino-4-aryl-substituted- and 2-amino-4,5-
disubstituted-thiazoles. Proc. Okla. Acad. Sci. 1991, 71, 29–33.
. Sharma, P. K.; Swonhney, S. N.; Gupta, A.; Singh, G. B.; Bani, S. Synthesis of some novel
2,4-disubstituted thiazoles. Indian J. Chem. 1998, 37B, 371–375.
. Schulze, K.; Richter, F.; Seisheit, R.; Krause, R.; Muhlstadt, M. Zur Darstellung und
Charakterisierung von Vinylsenf o¨ len. J. Prakt. Chem. 1980, 322, 629–637.
. Jackson, A.; Heyes, G.; Grayson, J. I.; Clarke, R. Preparation of substituted thiazoles.
U.S. Patent 5,705,652, Jan. 6, 1998.
. Leanna, R. M.; Morton, H. E. Process for preparation of 5-hydroxymethylthiazole. PCT
Int. Appl. WO Patent 09616050, May 30, 1996; Chem. Abstr. 1996, 125, 114603d.
. Bai, R.; Covell, D. G.; Taylor, G. F.; Kepler, J. A.; Copeland, T. D.; Nguyen, N. Y.;
Pettit, G. R.; Hamel, E. Direct photoaffinity labeling by dolastatin 10 of the
amino-terminal peptide of b-tubulin containing cysteine 12. J. Biol. Chem. 2004, 279,
30731–30740.
8. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.;
Gutkind, J. S.; Sausville, E. A.; Loaiza, A. I. The antitumor drug candidate 2-(4-amino-
3-methylphenyl)-5-fluorobenzo-thiazole. Anticancer. Drugs 2005, 16, 137–143.
9. Hargrave, K. D.; Hess, F. K.; Oliver, J. T. N-(4-Substituted-thiazolyl) oxamic acid deri-
vatives, new series of potent, orally active antiallergy agents. J. Med. Chem. 1983, 26,
1158–1163.
1
1
0. Patt, W. C.; Hamilton, H. W.; Taylor, M. D.; Ryan, M. J.; Taylor, D. J. J.; Connoly, C. J.
C.; Doherty, A. M.; Klutchko, S. R.; Sircar, I.; Steinbaugh, B. A.; Batly, B. L.; Painchaud,
C. A.; Rapundalo, S. T.; Michniewicz, B. M.; Olson, S. C. J. Structure–activity relation-
ships of a series of 2-amino-4-thiazole-containing renin inhibitors. J. Med. Chem. 1992, 35,
2562–2572.
1. Haviv, F.; Ratajczyk, J. D.; DeNet, R. W.; Kerdesky, F. A.; Walters, R. L.; Schmidt, S.
P.; Holms, J. H.; Young, P. R.; Carter, G. W. 3-[1-(2-Benzoxazolyl)hydrazino]propaneni-
trile derivatives: Inhibitors of immune complex–induced inflammation. J. Med. Chem.
1988, 31, 1719–1728.
1
2. Tsuji, K.; Ishikawa, H. Synthesis and anti-pseudomonal activity of new 2-isocephems with
a dihydroxypyridone moiety at C-7. Bioorg. Med. Chem. Lett. 1994, 4, 1601–1606.
3. Bell, F. W.; Cantrell, A. S.; Hoberg, M.; Jaskunas, S. R.; Johansson, N. G.; Jordon, C. L.;
Kinnick, M. D.; Lind, P.; Morin, Jr., J. M.; Noreen, R.; Oberg, B.; Palkowitz, J. A.;
Parrish, C. A.; Pranc, J.; Zhang, H.; Zhou, X.-X. Phenethylthiazolethiourea (PETT)
compounds, a new class of HIV-1 reverse transcriptase inhibitors, 1: Synthesis and basic
structure–activity relationship studies of PETT analogs. J. Med. Chem. 1995, 38,
1
4929–4936.
14. Cave, G. W. V.; Raston, C. L.; Scott, J. L. Recent advances in solventless organic
reactions: Towards benign synthesis with remarkable versatility. Chem. Commun. 2001,
2159–2169.
1
1
5. Tanaka, K. Solvent-Free Organic Synthesis; Wiley-VCH: Weinheim, 2003.
6. Potewar, T. M.; Ingale, S. A.; Srinivasan, K. V. Efficient synthesis of 2,4-disubstituted
thiazoles using ionic liquid under ambient conditions: A practical approach towards the
synthesis of fanetizole. Tetrahedron 2007, 63, 11066–11069.